Investigation Overview
After TomoTherapy Incorporated announced that its board of directors agreed to a takeover by Accuray an investigation on behalf of investors of TomoTherapy Incorporated (NASDAQ:TOMO) concerning the potential unfairness of the takeover and possible breaches of fiduciary duty was announced. The investigation by a law firm concerns whether certain directors and officers at TomoTherapy I...
You must register (for free) or login to view the entire investigation.